SAT0333 Drug survival on first tnf inhibitors in patients with psoriatic arthritis: comparison acros...
SAT0333 Drug survival on first tnf inhibitors in patients with psoriatic arthritis: comparison across etanercept, adalimumab, golimumab and infliximab
About this item
Full title
Author / Creator
Publisher
Kidlington: Elsevier Limited
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: Elsevier Limited
Subjects
More information
Scope and Contents
Contents
BackgroundIt is commonly accepted that additional methotrexate (MTX) does not increase efficacy for treatment with TNF in psoriatic arthritis (PsA) but concomitant MTX has been also associated with increased drug survival in register studies. However, the role of MTX comedication in PsA is still unclear.ObjectivesWe aim was to evaluate TNF-α inhibi...
Alternative Titles
Full title
SAT0333 Drug survival on first tnf inhibitors in patients with psoriatic arthritis: comparison across etanercept, adalimumab, golimumab and infliximab
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2071212311
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2071212311
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2018-eular.4951
